Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Caffeine citrate
Drug ID BADD_D00333
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D07603
MeSH ID C026189
PubChem ID 6241
TTD Drug ID Not Available
NDC Product Code 25021-602; 72485-104; 0517-0020; 0641-6267; 42571-244; 51754-0500; 55150-187; 63323-407; 72485-110; 25021-601; 47335-289; 47335-290; 51754-0503; 42571-346; 51754-0502; 63323-406; 51754-0501
UNII U26EO4675Q
Synonyms caffeine citrate | Cafcit
Chemical Information
Molecular Formula C14H18N4O9
CAS Registry Number 69-22-7
SMILES CN1C=NC2=C1C(=O)N(C(=O)N2C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acidosis14.01.03.002--
Blood calcium increased13.11.01.003--Not Available
Blood glucose abnormal13.02.02.008--Not Available
Blood sodium increased13.11.01.013--Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Creatinine renal clearance increased13.13.01.015--Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.002--
Dry skin23.03.03.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Feeling jittery08.01.09.016--Not Available
Gastritis07.08.02.001--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal stenosis07.13.01.007--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hypoglycaemia14.06.03.001; 05.06.03.001--
Impaired healing08.03.02.001--Not Available
Injury12.01.08.004--Not Available
Irritability19.04.02.013; 08.01.03.011--
Pulmonary oedema22.01.03.003; 02.05.02.003--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Restlessness19.11.02.002; 17.02.05.021--
Retinopathy of prematurity18.04.01.004; 12.02.02.015; 06.10.02.012--Not Available
Sepsis11.01.11.003--
Skin disorder23.03.03.007--Not Available
Stroke volume increased13.14.02.004--Not Available
Tachycardia02.03.02.007--Not Available
Urine flow decreased20.02.02.012--Not Available
Increased ventricular afterload13.14.02.014--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages